The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine
Recruiting · NCT07023926 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Sham electroacupunctureelectroacupuncture
What this trial is about
Acupuncture is commonly used for the prevention of migraine and tension-type headaches, and has been found to be effective in reducing both the frequency and severity of these conditions. However, studies on acupuncture for menstrually related migraine (MRM) are limited, and current research has not been able to determine whether its efficacy is due to the actual therapeutic effects of acupuncture or psychological benefits. To address this issue, the investigators have designed a clinical trial to evaluate the efficacy of acupuncture for MRM.
Who can take part
Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- meet the diagnostic criteria for MRM according to the ICHD-3, with a documented history of MRM for at least 12 months;
- have a confirmed diagnosis of migraine by a neurologist;
- aged 18-45 years;
- have regular menstrual cycles (28 ± 7 days) with menstruation lasting 3-7 days;
- have experienced ≥3 headache days during each menstrual cycle (days -2 to +3) and ≥5 total headache days per cycle over the past 3 months and baseline period; migraine attacks must last 4-72 hours without acute medication, or at least 2 hours when treated;
- have completed a headache diary during the screening period (covering at least one full menstrual cycle), demonstrating good compliance;
- headache diary data during screening period must meet the ICHD-3 criteria for MRM and fulfill criteria (4) and (5);
- voluntarily sign the informed consent.
Exclusion criteria
- irregular menstrual cycles, defined as cycle length outside the range of 28±7 days or menstruation duration \<3 days or \>7 days;
- presence of secondary headache disorders, facial neuralgia, or cranial neuralgia;
- combined with serious primary diseases such as cardiovascular, hepatic, renal, gastrointestinal, or hematological disorders that may interfere with the treatment protocol, or comorbid neurological conditions such as epilepsy, parkinson's disease, or other central nervous system disorders;
- headache symptoms caused by other conditions, such as moderate to severe head or neck trauma, perimenstrual infections, intracranial tumors, intracranial infections, endocrine or metabolic disorders;
- receipt of preventive treatment for headache within 1 month prior to the screening visit;
- afraid of needles or received acupuncture treatment within 3 months;
- unwillingness to undergo the study intervention or failure to sign the informed consent.
Where it is running
1 location listed.
- Department of Acupuncture, China Academy of Chinese Medical Sciences Guang'anmen Hospital - Beijing, Beijing Municipality, China